News

REGENXBIO Announces Participation in Key Investor Conferences

REGENXBIO Announces Participation in Key Investor Conferences

Upcoming Investor Conferences for REGENXBIO Inc.

REGENXBIO Inc. (Nasdaq: RGNX) has made an exciting announcement regarding its participation in several key upcoming investor conferences that hold significant value for stakeholders and potential investors alike. These conferences are great opportunities for REGENXBIO to showcase its innovative approach and advancements in gene therapy.

Wells Fargo Healthcare Conference

First on the agenda is the 2025 Wells Fargo Healthcare Conference, where REGENXBIO is set to engage in one-on-one investor meetings on an upcoming Thursday. This will allow direct interaction between the company and its investors, providing a platform for discussing the latest developments and potential future endeavors.

Morgan Stanley 23rd Annual Global Healthcare Conference

Following closely, REGENXBIO will take part in the renowned Morgan Stanley 23rd Annual Global Healthcare Conference. During this event, scheduled for a Monday, a special fireside chat is planned for 11:30 a.m. ET, where the company’s leaders will dive into discussions about their strategic goals and how REGENXBIO plans to advance its mission of improving lives through gene therapy.

Baird Global Healthcare Conference

Next, on the schedule is the Baird 2025 Global Healthcare Conference, unfolding with another engaging fireside chat. This session is set for a Tuesday morning at 8:30 a.m. ET. This conference serves as an additional avenue for REGENXBIO to connect with investors, shedding light on their ongoing projects and innovations.

H.C. Wainwright Annual Global Investment Conference

Moreover, REGENXBIO will also present at the H.C. Wainwright 27th Annual Global Investment Conference. This event is lined up for later in the same week, where another fireside chat will take place. This chat will focus on the company’s latest advancements in gene therapies and its expansive pipeline.

Access to Live Webcasts

For those interested in following along, REGENXBIO will be offering live webcasts of select fireside chats via its Investors section on the company’s website. Additionally, archived recordings will be available for a period of 30 days post-event, ensuring that stakeholders don’t miss out on any important information shared during these discussions.

About REGENXBIO Inc.

Founded in 2009, REGENXBIO has emerged as a leading biotechnology company dedicated to improving lives through the remarkable potential of gene therapy. The company is recognized for its pioneering efforts in the AAV (adeno-associated virus) gene therapy field, consistently working towards developing innovative solutions for rare diseases. REGENXBIO’s late-stage pipeline showcases treatments for various conditions, such as Duchenne muscular dystrophy and certain metabolic disorders, underscoring its commitment to transformative healthcare.

Contacts for Further Information

To learn more about REGENXBIO and its exciting advancements in gene therapy, interested parties can reach out to the corporate communications team. For investors looking for detailed insights, the investor relations department is available to provide additional information and answer any queries.

Frequently Asked Questions

1. When are the upcoming investor conferences for REGENXBIO?

REGENXBIO will participate in several conferences, starting with the Wells Fargo Healthcare Conference on September 4, followed by others through September 9.

2. How can I access the webcasts of the conferences?

Live webcasts of select fireside chats will be available on REGENXBIO’s website, with recordings accessible for approximately 30 days after the events.

3. What is the main focus of REGENXBIO?

The company focuses on improving lives through gene therapy, developing innovative treatments for rare and retinal diseases.

4. Who can I contact for more information?

For corporate communications, you can connect with the team at REGENXBIO, or reach out to the investor relations department for investment-related inquiries.

5. What types of therapies is REGENXBIO developing?

REGENXBIO is advancing a pipeline of one-time gene therapies targeting rare diseases, including treatments for Duchenne muscular dystrophy and metabolic disorders.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Brinker International Posts Solid Q1 2027 Earnings

Updated Category News Views 80

Strong Earnings Highlight a Winning Streak Brinker International, folks, has done it again. With the latest release of their first quarter fiscal 2027 results, it’s clear they’ve been hitting the right notes, especially at Chili’s. The numbers don't lie—trust me, I've seen my fair share of earnings calls, and this one's got meat on the bones. Let’s break it...

Continue Reading
E-Bike Demo Day Spurs New Jersey's Policy Insights

Updated Category News Views 79

Velotric Sets the Stage for E-Bike Insights The chatter over at Trenton has been electric—and I mean that literally. On October 29, Assemblywoman Tennille R. McCoy will open the gates of the New Jersey State House to host an E-Bike Demonstration and Education Day. The goal? To slap some sense into lawmakers' understanding of the buzzing e-bike market. Velotric, a major...

Continue Reading
Innovative Trial Targets Drug Resistance in Lung Cancer

Updated Category News Views 68

The Battle Against Drug Resistance Heats Up Folks, we're in a never-ending fight here against one of the toughest adversaries out there: lung cancer. And lemme tell ya, when drugs show resistance, it's like trying to punch a ghost. But there’s a fresh wind blowing, as Dr. Bobak Parang steps up to the plate with a $620K grant aimed squarely at tackling drug resistance in...

Continue Reading
ReachWell Revamps Platform for Better Community Reach

Updated Category News Views 79

ReachWell's Fresh Approach: A New Era Begins Become the whisper in the wind reaching ears far and wide—enter the new ReachWell. Sounds lofty? Well, it's shooting for the stars here, folks. This isn’t just some tech upgrade. It’s a whole new brand identity and a refreshed sense of purpose. These guys have tossed everything back on the drawing board, unveiling a...

Continue Reading
H.R. 10549: Hope Charities Pushes for Pharmacy Freedom

Updated Category News Views 63

Hope Charities Takes a Stand for Patients In Prairieville, Hope Charities is throwing its weight behind a bill they believe is brewing up a patient revolution. The Patients Choice in Specialty Pharmacy Act, otherwise known as H.R. 10549, sparked by Representatives Neal Dunn and Joe Wilson, tackles the comfortable partnerships some insurers have been enjoying with their...

Continue Reading
Genefluence Launches Rapid UTI PCR Test at Chelsea Hospital

Updated Category News Views 49

There's a fresh breeze blowing through the dusty corridors of healthcare, shaking things up for the better. You see, Genefluence, the brainchild of Professor Chris Toumazou, isn't just throwing a bunch of tech jargon around—it's setting the stage for a much-needed shake-up in how we handle urinary tract infections (UTIs) and, believe me, it couldn’t have come sooner....

Continue Reading
Labcorp Lifts 2026 Guidance Amid Strong Q3 Performance

Updated Category News Views 119

Labcorp's Q3 Numbers Speak Loud and Clear Another quarter, another robust set of numbers for Labcorp (NYSE:LH). The company is strutting into the spotlight with third-quarter 2026 results that have investors nodding in approval. Revenue surged to $3.81 billion, marking a 6.9% increase from the prior year's $3.56 billion. And get this: adjusted EPS jumped 14.5%, clocking...

Continue Reading
7-Eleven Rolls Out Korean Flavors in Bold Menu Shift

Updated Category News Views 68

7-Eleven's New Global Menu Twist October 2026 sees 7-Eleven, Inc. whip out an intriguing move, venturing east with its new Flavors of Korea menu. They're not just changing the game in convenience store aisles; they're dancing to the beat of global flavors—a shake-up fit for the world's largest convenience retailer. Think about bodega basics getting a spicy Korean...

Continue Reading
AEP's $100B Power Plan: Investing in Tomorrow's Energy

Updated Category News Views 85

Electricity Powerhouse Unleashes Ambitious Plan If you thought American Electric Power (NASDAQ:AEP) was just cruising along, think again. This week, they rolled out an eye-popping $100 billion plan to supercharge their infrastructure and meet soaring electricity demands. It’s like they’re building the future of power right in front of our eyes. Third-quarter earnings...

Continue Reading
Hallmark's Holiday Magic: Cards, Ornaments, Joy

Updated Category News Views 205

Hallmark's Seasonal Bonanza: Cards, Gifts, and More It's that time again when Hallmark rolls out the holiday carpet, the red one you usually just see in front of fancy theaters. Greeting cards, gifts, Keepsake Ornaments, and those nostalgic holiday flicks on Hallmark Channel—it's a full-on festive fiesta. But it's not just about shoving a card in an envelope; it's about...

Continue Reading

Top 5 Most Recently Viewed Articles

3 Undervalued Tech Stocks to Consider for Growth This Quarter

Updated Category News Views 253

Understanding Oversold Tech Stocks The information technology sector often presents incredible investment opportunities, especially when stocks become oversold. Oversold stocks can indicate that a company is undervalued, making it an attractive buy for investors. Identifying these stocks is essential for potential gains. What is RSI? The Relative Strength Index (RSI) is a...

Continue Reading
Exciting Developments for Chaos Zero Nightmare RPG Game

Updated Category News Views 263

Exciting Developments for Chaos Zero Nightmare RPG Game Chaos Zero Nightmare (CZN) is making waves in the gaming community with outstanding pre-registration numbers. The RPG has reached an impressive milestone of over 1 million pre-registrations, creating anticipation for its unique gameplay and rich storytelling, set in a dark and chaotic world. Unique Features in Chaos...

Continue Reading
Square Enhances Beauty and Wellness Offerings Through New Features

Updated Category News Views 209

Overview of Square's New Partnerships and Features Square, committed to empowering beauty and wellness sellers, has unveiled exciting new partner integrations and features that aim to enhance their operational efficiency and growth. Partnering with leading distributor SalonCentric, Square is expanding its hardware and software solutions to a larger community of beauty...

Continue Reading
Major Stock Sale by Penumbra CEO Adam Elsesser Raises Interest

Updated Category News Views 262

CEO of Penumbra Makes a Major Stock Sale Recently, Adam Elsesser, who serves as the CEO and President of Penumbra Inc (NYSE:PEN), grabbed attention after selling over $2.9 million worth of shares in the company. This noteworthy decision is prompting both investors and market analysts to carefully evaluate what this means for Penumbra's future. Such sales are significant...

Continue Reading
Viper Energy Completes Major Acquisition Enhancing Its Portfolio

Updated Category News Views 167

Viper Energy's Significant Acquisition Announcement Viper Energy, Inc. (NASDAQ: VNOM), a notable subsidiary of Diamondback Energy, Inc. (NASDAQ: FANG), has recently finalized an important acquisition that promises to enhance its standing in the oil and gas market. This announcement, made in Midland, Texas, reflects Viper's strategic approach to expanding its assets in...

Continue Reading